Axsome Therapeutics, Inc. (AXSM)
169.95
-4.81
(-2.75%)
USD |
NASDAQ |
Feb 24, 16:00
168.10
-1.85
(-1.09%)
After-Hours: 20:00
Axsome Therapeutics Shareholders Equity (Annual) : 57.02M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 679.59M |
| Gilead Sciences, Inc. | 22.62B |
| Vanda Pharmaceuticals, Inc. | 327.19M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| Amicus Therapeutics, Inc. | 274.24M |